62
Participants
Start Date
December 5, 2023
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2028
Atezolizumab
Atezolizumab will be administered at a dose of 1200 mg by IV infusion on Day 1.
Bevacizumab
Bevacizumab will be administered at a dose of 15 mg/kg by IV infusion on Day 1.
Tiragolumab
Tiragolumab will be administered at a dose of 600 mg by IV infusion on Day 1.
Tobemstomig
Tobemstomig will be administered at a dose of 600 mg by IV infusion on Day 1
Taipei Veterans General Hospital, Taipei
Auckland District Health Board (ADHB), Auckland
Wiener Gesundheitsverbund, Klinik Favoriten, Vienna
Department of Internal Medicine III AKH and Medical University of Vienna, Vienna
Hospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona
Klinikum Klagenfurt am Wörthersee, Klagenfurt
Columbia University Medical Center, New York
National Taiwan University Hospital (NTUH) - Cancer Research Center, Zhongzheng Dist.
CHA Bundang Medical Center, Gyeonggi-do
Georgetown University Medical Center, Washington D.C.
Centre Georges Francois Leclerc (CGFL), Dijon
Hospital Universitario Fundacion Jimenez Diaz., Madrid
Clínica Universidad de Navarra, Pamplona
Centre Eugene Marquis (CEM), Rennes
Hospital Universitario Marques de Valdecilla, Santander
Taichung Veterans General Hospital, Taichung
University Essen, Essen
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz
Universitaets Klinikum Frankfurt - Zentrum der Inneren Medizin, Frankfurt
National Cheng Kung University Hospital, Tainan City
Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital, Tainan City
University of Southern California (USC), Los Angeles
Assistance Publique-Hopitaux de Paris, Villejuif
Gustave Roussy, Villejuif
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica, Santa Monica
Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus, Detroit
UT Southwestern Medical Center, Dallas
Fred Hutchinson/University of Washington Cancer Consortium, Seattle
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Belfast Health and Social Care Trust - Belfast City Hospital, Belfast
Imperial College London - Imperial Centre for Translational and Experimental Medicine (ICTEM), London
Hoffmann-La Roche
INDUSTRY